ESG
AGN

Emerging Sovereign Group’s Allergan plc AGN Stock Holding History

Emerging Sovereign Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-398,320
Closed -$92M – 23
2016
Q2 		$92M Buy
398,320
+83,340
+26% +$19.2M 6.33% 7
2016
Q1 		$84.4M Sell
314,980
-190,750
-38% -$54.6M 5.17% 9
2015
Q4 		$158M Sell
505,730
-33,970
-6% -$10.1M 7.97% 3
2015
Q3 		$147M Sell
539,700
-67,560
-11% -$20.8M 6.67% 4
2015
Q2 		$184M Buy
607,260
+106,560
+21% +$31.8M 6.68% 5
2015
Q1 		$149M Buy
+500,700
New +$143M 5.28% 7

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerging Sovereign Group's AGN Position: Q3 2016 in Review

Emerging Sovereign Group sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 398,320 shares — an estimated $92M sold.

Emerging Sovereign Group first reported a position in AGN in Q1 2015 and held it in 6 quarters. The position peaked at $184M in Q2 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Emerging Sovereign Group reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Emerging Sovereign Group sold 398,320 Allergan plc shares in Q3 2016, an estimated $92M.
  • Emerging Sovereign Group first reported a position in Allergan plc in Q1 2015 and held it in 6 quarters.
  • Emerging Sovereign Group's Allergan plc position peaked at $184M in Q2 2015.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Emerging Sovereign Group's 13F filing for Q3 2016, filed 14 Nov 2016.